Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

NCT05309460 is registered in ClinicalTrials.gov with Nebraska Methodist Health System as lead sponsor.

NCT NCT05309460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05309460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
Lead sponsor
Nebraska Methodist Health System
Phase
Phase 4
Overall status
Recruiting
Start date
June 20, 2022
Completion date
December 1, 2024
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension in pregnancy, postpartum preeclampsia